Chromium Nicotinate Has No Effect on Insulin Sensitivity, Glycemic Control, and Lipid Profile in Subjects with Type 2 Diabetes

Journal of the American College of Nutrition

Volumn 32, Issue 4, 2013, Pages 243-250

  Guimarães, Marília Mendonça ^a   Martins Silva Carvalho, Ana Clara ^a   Silva, Maria Sebastiana ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

chromium; clinical trial; insulin resistance; type 2 diabetes mellitus

Indexed keywords

CHROMIUM; CHROMIUM NICOTINATE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLACEBO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

ADULT; BLOOD GLUCOSE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHROMIUM; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NICOTINIC ACIDS; ORGANOMETALLIC COMPOUNDS;

EID: 84884271027     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2013.816598     Document Type: Article

References (28)

1. Martin, J, Wang, Q Z, Zang, H X, Wachtel, D, Volaufova, J, Matthews, D E and Cefalu, W T. 2006. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care, 29: 1826 - 1838.
2. Sharma, S, Agrawal, R P, Choudhary, M, Jain, S, Goyal, S and Agarwal, V. 2011. Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes. J Trace Elem Med Biol, 25: 149 - 153.
3. Chen, G, Liu, P, Pattar, G R, Tackett, L, Bhonagiri, P, Strawbridge, A B and Elmendorf, J S. 2006. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol, 20: 857 - 870.
4. Pattara, G R, Tacketta, L, Liua, P and Elmendorf, J S. 2006. Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions. Mutat Res, 610: 93 - 100.
5. Vicent, J B. 1999. Mechanisms of chromium action: low-molecular-weight chromium binding substance. J Am Coll Nutr, 18: 6 - 12.
6. Althuis, M D, Jordan, N E, Ludington, L A and Wittes, J T. 2002. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr, 76: 48 - 55.
7. Institute of Medicine. 2001. " Chromium ". In Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc, 197 - 223. Washington, DC: The National Academy Press.
8. Anderson, R A. 2003. Chromium and insulin resistance. Nutr Res Rev, 16: 267 - 275.
9. World Health Organization. 1996. " Chromium ". In Trace Elements in Human Nutrition and Health, 155 - 160. Geneva, Switzerland: World Health Organization.
10. Gamez, A A, Saenz, R B and Morales, E M. 2002. Chromium as an essential element in humans. Rev Costarric de Cienc Med, 23: 55 - 68.
11. Committee on Dietary Allowances, Food and Nutrition Board. 1989. " Chromium ". In Recommended Dietary Allowances (RDA)., 10th rev. ed, 241 - 243. Washington, DC: National Academy of Science.
12. Kleefstra, N, Sebastiaan, T, Houweling, S T, Bakker, S JL, Verhoeven, S, Gans, R OB, Meyboom De Jong, B and Bilo, H JG. 2007. Chromium treatment has no effect in patients with type 2 diabetes in a Western population. Diabetes Care, 30: 1092 - 1096.
13. Cohen, J. 1988. Statistical Power for the Behavioral Sciences, Mahwah, NJ: Lawrence Erlbaum Associates.
14. Moher, D, Hopewell, S, Schulz, K F, Montori, V, Gotzsche, P C, Devereaux, P J, Elbourne, D, Egger, M, Altman, D G and for the CONSORT Group. 2010. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trial. BMJ, 340: c869
15. Ellis, S, Shumaker, S, Sieber, W and Rand, C. 2000. Adherence to pharmacological interventions: current trends and future directions. Control Clin Trials, 21: 218S - 225S.
16. Silva, C S. 2003. " Chromium ". In Metals management of toxicity, 1st ed, Edited by: Azevedo, F A and Chasin, A AM. 35 - 66. São Paulo, Brazil: Editora Atheneu.
17. Brazil. Ministry of Labour and Employment: Regulatory standard number 7. Control Program Occupational Health. Federal Official Gazette of Brazil July 6, 1978. Accessed at: http://portal.mte.gov.br/data/files/8A7C812D308E21660130E0819FC102ED/nr_07.pdf
18. Matthews, D R, Hosker, J R, Rudenski, A S, Naylor, B A, Treacher, D F and Turner, R C. 1985. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28: 412 - 419.
19. Geloneze, B, Vasques, A CJ, Stabe, C FC, Pareja, J C, Rosado, LEFPL, Queiroz, E C and Tambascia, M A. 2009. HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome-Brasilian Metabolic Syndrome Study (BRAMS). Arq Bras Endocrinol Metabol, 53: 281 - 287.
20. Wallace, T M, Levy, J C and Matthews, D R. 2004. Use and abuse of HOMA modeling. Diabetes Care, 27: 1487 - 1495.
21. Hedeker, D and Gibbons, R D. 2006. Longitudinal Data Analysis, New York, NY: John Wiley.
22. Vicent, J B. 2000. The biochemistry of chromium. J Nutr, 130: 715 - 718.
23. Gosh, D, Bhattacharya, B, Mukherjee, B, Manna, B, Sinha, M, Chowdhury, J and Chowdhury, C. 2002. Role of chromium supplementation in Indians with type 2 diabetes mellitus. J Nutr Biochem, 13: 690 - 697.
24. Cefalu, W, Rood, J, Pinsonat, P, Qin, J, Sereda, O, Levitan, L, Anderson, R, Zhang, X, Martin, J M, Martin, C K, Wang, Z Q and Newcomer, B. 2010. Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus. Metabolism, 59: 755 - 762.
25. American Diabetes Association. 2011. Standards of medical care in diabetes-2011. Diabetes Care, 34: S10 - S61.
26. Gunton, J E, Cheung, N W, Hitchman, R, Hams, G, O'sullivan, C, Foster-Powell, K and Mceldulff, A. 2005. Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile. Diabetes Care, 28: 712 - 713.
27. Anderson, R A, Cheng, N, Bryden, N A, Polansky, M M, Cheng, N, Chi, J and Feng, J. 1997. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes, 46: 1786 - 1791.
28. Anderson, R A. 2008. Chromium and polyphenols from cinnamon improve insulin sensitivity. Proc Nutr Soc, 67: 48 - 53.